Knockdown of RBP-Jk expression decreased proliferation of breast and prostate cancer cells, but GSI treatment induced minimal growth effects, further suggesting that RBP-Jk has Notch-independent roles [56]. The gene discussed is RBPJ; the disease is prostate cancer.